| Literature DB >> 35422636 |
Wondwossen Tsegaye1, Adane Bitew2, Addisu Gize3.
Abstract
Background: Understanding the proportion of blood and blood products contamination during transfusion is important in developing infection control strategy in the health system. Therefore, this study was aimed to determine bacterial contamination and susceptibility patterns among blood and blood components at Armed Forces Comprehensive Specialized Hospital, Addis Ababa, Ethiopia.Entities:
Keywords: bacterial contamination; blood culture; diverging and non-diverging method; susceptibility pattern
Year: 2022 PMID: 35422636 PMCID: PMC9004673 DOI: 10.2147/IDR.S360515
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Sample Characteristics of Blood and Blood Components in AFCSH Addis Ababa City, Ethiopia, 2018
| Types of Blood and Blood Components | Donor Blood Collection Method | Total (%) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Non-Diverging (%) | Diverging (%) | ||||||||
| Whole blood | 47(25) | 47 (25) | 94 (25) | ||||||
| PRBC | 47 (25) | 47 (25) | 94 (25) | ||||||
| FFP | 47 (25) | 47 (25) | 94(25) | ||||||
| Platelet | 47(25) | 47 (25) | 94(25) | ||||||
| Total | 188 (100) | 188 (100) | 376 (100) | ||||||
| Whole blood | 20(21.3) | 2(2.1) | 23(24.5) | 1(1.1) | 12(12.8) | 1(1.1) | 32(34) | 3(3.2) | 94(100) |
| PRBC | 18(19.1) | 2(2.1) | 19(20.2) | 4(4.3) | 11(11.7) | 2(2.1) | 36(38.3) | 2(2.1) | 94(100) |
| FFP | 21(22.3) | 1(1.1) | 17(18.1) | 2(2.1) | 18(19.1) | 1(1.1) | 39(31.9) | 4(4.3) | 94(100) |
| Platelet | 19(20.2) | 1(1.1) | 23(24.5) | 2(2.1) | 4(4.3) | 1(1.1) | 39(41.5) | 5(5.3) | 94(100) |
| Total | 78(20.7) | 6(1.6) | 82(21.8) | 9(2.4) | 45(12) | 5(1.3) | 137(36.4) | 14(3.7) | 376(100) |
| Whole blood | 0(0) | 0(0) | 0(0) | 0(0) | 0(0) | 0(0) | 94(100) | 94(100) | 0(0) |
| PRBC | 0(0) | 0(0) | 0(0) | 0(0) | 0(0) | 0(0) | 94(100) | 94(100) | 0(0) |
| FFP | 44(46.8) | 21(22.3) | 29(30.9) | 0(0) | 0(0) | 0(0) | 0(0) | 94(100) | 44(46.8) |
| Platelet | 0(0) | 0(0) | 0(0) | 23(24.5) | 53(56.3) | 18(19.1) | 0(0) | 94(100) | 0(0) |
| Total | 44(11.7) | 21(5.6) | 29(7.7) | 23(6.3) | 53(14.1) | 18(4.8) | 188(49.8) | 376(100) | 44(11.7) |
| Whole blood | 0(0) | 26(27.7) | 18(19.1) | 25(26.6) | 21(22.3) | 4(4.3) | 0(0) | 0(0) | 94(100) |
| PRBC | 0(0) | 11(11.7) | 51(54.3) | 17(18.1) | 12(12.8) | 3(3.2) | 0(0) | 0(0) | 94(100) |
| FFP | 0(0) | 5(5.3) | 13(13.8) | 2(2.1) | 1(1.1) | 25(26.6) | 18(19.1) | 30(31.9) | 94(100) |
| Platelet | 94(100) | 0(0) | 0(0) | 0(0) | 0(0) | 0(0) | 0(0) | 0(0) | 94(100) |
| Total | 94(100) | 42(11.2) | 82(21.8) | 44(11.7) | 34(9) | 32(8.5) | 18(4.8) | 30(8) | 376(100) |
Abbreviations: PRBC, packed red blood cell; FFP, fresh frozen plasma; OC, degree centigrade; dys, days.
Multivariable Analysis of Bacterial Contamination Among Blood and Blood Components at AFCSH, Ethiopia, 2018
| Characteristics | Positive N (%) | Negative N (%) | Total N (%) | COR (95% CI) | P- value | AOR (95% CI) | P- value |
|---|---|---|---|---|---|---|---|
| Non-diverging | 14 (7.4) | 174 (92.6) | 188 (50) | 4.96 (1.4–17.6) | 0.013 | 7.75 (1–60.1)1 | 0.05 |
| Diverging | 3 (1.6) | 185 (98.4) | 188 (50) | 1 | |||
| WBCs | 6 (35.3) | 88(24.5) | 94 (25) | 2.07 (0.5–8.53) | 0.31 | ||
| PRBCs | 6 (35.3) | 88 (24.5) | 94 (25) | 2.07 (0.5–8.53) | 0.31 | ||
| Platelets | 3 (17.6) | 91 (25.3) | 94 (25) | 0.66 (0.1–4.04) | 0.65 | ||
| FFP | 2 (11.8) | 92 (25.6) | 94 (25) | 1 | 1 | ||
| Total | 17 (100) | 359 (100) | 376 (100) |
Antimicrobial Susceptibility Pattern of Gram-Positive Bacteria Collected by Non-Diverging Method, 2018
| Bacterial | N | P | GEN | CTR | CLD | AMK | CXT | AMP | COT | PEN | ERY | TOB | CHL | CXM | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Isolates | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | ||
| 4 | S | 3 (75) | ND | 3 (75) | 3 (75) | 4 (100) | ND | 3 (75) | 3 (75) | 3 (75) | 4 (100) | ND | ND | 26 (81) | |
| I | 1 (25) | ND | 1 (25) | 1 (25) | 0 (0) | ND | 1 (25) | 0 (0) | 0 (0) | 0 (0) | ND | ND | 4 (13) | ||
| R | 0 (0) | ND | 0 (0) | 0 (0) | 0 (0) | ND | 0 (0) | 1 (25) | 1 (25) | 0 (0) | ND | ND | 2 (6) | ||
| 4 | S | 4 (100) | ND | 4 (100) | 4 (100) | 2 (50) | ND | 2 (50) | 3 (75) | 2 (50) | 4 (100) | ND | ND | 25 (78) | |
| I | 0 (0) | ND | 0 (0) | 0 (0) | 0 (0) | ND | 0 (0) | 0 (0) | 1 (25) | 0 (0) | ND | ND | 1 (3) | ||
| R | 0 (0) | ND | 0 (0) | 0 (0) | 2 (50) | ND | 2 (50) | 1 (25) | 1 (25) | 0 (0) | ND | ND | 6 (19) | ||
| 2 | S | 2 (100) | 2 (100) | ND | ND | ND | 2 (100) | 1 (50) | 2 (100) | 1 (50) | 2 (100) | 1 (50) | 2 (100) | 15 (83) | |
| I | 0 (0) | 0 (0) | ND | ND | ND | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (50) | 0 (0) | 1 (6) | ||
| R | 0 (0) | 0 (0) | ND | ND | ND | 0 (0) | 1 (50) | 0 (0) | 1 (50) | 0 (0) | 0 (0) | 0 (0) | 2 (11) | ||
| 1 | S | 1 (100) | 1 (100) | ND | ND | ND | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 9 (100) | |
| I | 0 (0) | 0 (0) | ND | ND | ND | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | ||
| R | 0 (0) | 0 (0) | ND | ND | ND | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | ||
| Total | 1 | S | 10 (91) | 3 (100) | 7 (88) | 7 (88) | 6 (75) | 3 (100) | 7(64) | 9 (82) | 7(64) | 11 (100) | 2 (67) | 3 (100) | 75 (85) |
| 1 | I | 1 (9) | 0 (0) | 1 (22) | 1 (22) | 0 (0) | 0 (0) | 1 (9) | 0 (0) | 1 (9) | 0 (0) | 1 (33) | 0 (0) | 6 (6) | |
| R | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 2(25) | 0 (0) | 3 (27) | 2 (18) | 3 (27) | 0 (0) | 0 (0) | 0 (0) | 10 (9) | ||
Abbreviations: N, number; P, pattern; ND, not done; GEN, gentamicin; CTR, ceftriaxone; CLD, clindamycin; AMK, amikacin; CXT, cefoxitin; AMP, ampicillin; COT, trimethoprim-sulphamethoxazole; PEN, penicillin; ERY, erythromycin; TOB, tobramycin; CHL, chloramphenicol; CXM, cefotaxime; S, sensitive; I, intermediate; R, resistant.
Antimicrobial Susceptibility Pattern of Gram-Negative Bacteria Collected by Non-Diverging Method, 2018
| Bacterial | N P | GEN | CPR | CTR | AMK | MER | CFP | PIP- | COT | AUG | TOB | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Isolates | TAZ | ||||||||||||
| N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | |||
| Klebsiella spp | 1 | S | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 0 (0) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 9 (90) |
| I | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (10) | ||
| R | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | ||
| 1 | S | 0 (0) | 1 (100) | 1 (100) | 1 (100) | 0 (0) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 8 (80) | |
| I | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 2 (20) | ||
| R | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | ||
| 1 | S | 0 (0) | 1 (100) | ND | 1 (100) | 1 (100) | 1 (100) | 1 (100) | ND | ND | 1 (100) | 6 (85.7) | |
| I | 0 (0) | 0 (0) | ND | 0 (0) | 0 (0) | 0 (0) | 0 (0) | ND | ND | 0 (0) | 0 (0) | ||
| R | 1 (100) | 0 (0) | ND | 0 (0) | 0 (0) | 0 (0) | 0 (0) | ND | ND | 0 (0) | 1 (14.3) | ||
| Sub Total | 3 | S | 3 (33.3) | 3 (100) | 2 (100) | 3 (100) | 1 (33) | 3 (100) | 3 (100) | 2 (100) | 2 (100) | 3 (100) | 23 (85.2) |
| I | 3 (33.3) | 0 (0) | 0 (0) | 0 (0) | 2 (67) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 3 (11.1) | ||
| R | 1 (33.3) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (3.7) | ||
Abbreviations: N, number; P, pattern; ND, not done; GEN, gentamicin; CPR, ciprofloxacin; CTR, ceftriaxone; AMK, amikacin; MER, meropenem; CFP, cefepime; PIP, TAZ, piperacillin-tazobactam; COT, trimethoprim-sulphamethoxazole; AUG, amoxicillin+ clavulanic acid; TOB, tobramycin; S, sensitive; I, intermediate; R, resistant.
Multidrug Resistant Level of Isolated Bacteria Collected by Non-Diverging and Diverging Method, 2018
| Number of Bacterial Isolates (n) | Non-Divergent Method | Divergent Method | Number of MDR | ||
|---|---|---|---|---|---|
| R0 | R1 | R0 | R1 | ||
| N (%) | N (%) | N (%) | N (%) | N (%) | |
| 4(23.5%) | 0(0) | 0(0) | 0(0) | 0(0) | |
| 3(17.65%) | 1(5.88%) | 0(0) | 2(11.76%) | 3(17.65%) | |
| 1(5.88%) | 1(5.88%) | 0(0) | 0(0) | 1(5.88%) | |
| 1(5.88%) | 0(0) | 0(0) | 1(5.88%) | 1(5.88%) | |
| 1(5.88%) | 0(0) | 0(0) | 0(0) | 0(0) | |
| 1(5.88%) | 0(0) | 0(0) | 0(0) | 0(0) | |
| 1(5.88%) | 0(0) | 0(0) | 0(0) | 0(0) | |
| Total (17) | 12(70.6%) | 2(11.76%) | 0(0) | 3(17.64%) | 5(29.4%) |
Abbreviations: N, number; MDR, multidrug-resistant; R0, isolates which were sensitive for all/intermediate for at least one antibiotics/resistant for one antibiotics; R1, resistant for one group of antibiotics.